Monday, June 13, 2011 6:37:23 PM
Event status: Not started (Register)
Date and time: Thursday, June 16, 2011 2:00 pm
Eastern Daylight Time (New York, GMT-04:00)
Change time zone
Duration: 1 hour
Description: Presented by:
Judd W. Moul, MD
Professor of Surgery and Chief, Division of Urologic Surgery
Director, Duke Prostate Center
Duke University Medical Center
Durham, NC
At the conclusion of this program, participants will be able to:
• Discuss advantages and disadvantages of prostate cancer screening using prostate specific antigen (PSA)
• Summarize important data and learnings about PSA from recent randomized clinical trials
• Describe appropriate use of PSA, PSA derivatives and other biomarkers for prostate cancer diagnosis and treatment
• Evaluate options for the treatment for clinically localized prostate cancer, with an emphasis on biomarkers for active surveillance and/or diagnosis of disease aggressivenes
Recent HDVY News
- Form 8-K - Current report • Edgar (US Regulatory) • 09/18/2024 05:05:06 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/11/2024 07:50:25 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/06/2024 07:10:32 PM
VAYK Confirms Insider Buying at Open Market • VAYK • Nov 5, 2024 10:40 AM
Rainmaker Worldwide Inc. Announces Strategic Partnership Between Miranda Water Technologies and Fleming College • RAKR • Nov 4, 2024 12:03 PM
North Bay Resources Announces Assays up to 9.5% Copper at Murex Copper Project, British Columbia • NBRI • Nov 4, 2024 9:00 AM
Rainmaker Worldwide Inc. to Assume Direct, Non-Dealer Sales of Miranda Water Technologies in U.S. and Mexico in First Quarter of 2025 • RAKR • Nov 4, 2024 8:31 AM
CBD Life Sciences Inc. (CBDL) Launches High-Demand Mushroom Gummy Line for Targeted Wellness Needs, Tapping into a Booming $20 Billion Market • CBDL • Oct 31, 2024 8:00 AM
Nerds On Site Announces Q1 Growth and New Initiatives for the Remainder of 2024 • NOSUF • Oct 31, 2024 7:01 AM